Correction to: Mortality and cardiovascular events in diabetes mellitus patients at dialysis initiation treated with glucagon-like peptide-1 receptor agonists

Lignende værker

• Association of glucagon-like peptide-1 receptor agonists with cardiovascular and kidney outcomes in type 2 diabetic kidney transplant recipients
  af: Li-Chun Lin, et al.
  Udgivet: (2025-02-01)
• Association Between Glucagon-Like Peptide-1 Receptor Agonists and Major Adverse Cardiovascular Outcomes Based on Race and Sex Among Patients With and Without Diabetes Mellitus: A Meta-Analysis of Nine Randomized Controlled Trials
  af: Vikash Jaiswal, et al.
  Udgivet: (2026-01-01)
• Safety and Efficacy of Semaglutide in Patients With Chronic Kidney Disease, With or Without Type 2 Diabetes: A Systematic Review and Meta‐Analysis
  af: Ali Abdullah, et al.
  Udgivet: (2025-11-01)
• Mortality and cardiorenal outcomes among heart failure patients with zinc deficiency: a multicenter retrospective cohort study of 8,290 patients
  af: Yu-Min Lin, et al.
  Udgivet: (2025-04-01)
• Biochemical phenotypes of acute kidney injury and their association with major adverse kidney events
  af: Pablo Maggiani-Aguilera, et al.
  Udgivet: (2026-12-01)